Day: July 19, 2021
New York, July 19, 2021 (GLOBE NEWSWIRE) — Cosmetic Packaging Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Cosmetic Packaging Market Research Report, Materials, Product, Application and Region – Forecast till 2027” the market worth USD 64.61 billion by 2027, registering a CAGR of 5.47% during the forecast period (2021 – 2027), The market was valued at USD 48.78 billion in 2020.
The cosmetic packaging market outlook appears extremely positive. Increasing research and development activities and huge investments by packaging manufacturers are the latest cosmetic packaging market trends. Moreover, increasing consumer preference for high-quality products and changing lifestyles escalate the market on the global platform. With the increasing consumer focus on high-quality...
Guardian Capital Announces July 2021 Distributions for Guardian Capital ETFs
Written by Customer Service on . Posted in Dividend Reports And Estimates.
TORONTO, July 19, 2021 (GLOBE NEWSWIRE) — Guardian Capital LP announces the following regular cash distributions for the period ending July 31, 2021, in respect of the Guardian Capital ETFs listed below. In each case, the distribution will be paid on July 30, 2021 to unitholders of record on July 26, 2021. The ex-dividend date in each case is July 23, 2021. Exchange Traded Fund
Series of ETF Units
DistributionFrequency
TradingSymbol
Distribution Amount(per ETF Unit)Guardian Directed Equity Path ETF
Hedged
Monthly
GDEP
$0.0685Guardian Directed Equity Path ETF
Unhedged
Monthly
GDEP.B
$0.0652Guardian Directed Premium Yield ETF
Hedged
Monthly
GDPY
$0.1076Guardian Directed Premium Yield ETF
Unhedged
Monthly
GDPY.B
$0.1024About Guardian Capital LPGuardian Capital LP is the manager and portfolio manager of the Guardian...
Brookfield Infrastructure Agrees with ISS’ Recommendation to Vote AGAINST the Pembina Transaction and Files Revised Offer to Purchase Inter Pipeline Ltd.
Written by Customer Service on . Posted in Mergers And Acquisitions.
Brookfield Infrastructure agrees with the recommendation from leading independent proxy advisor, Institutional Shareholder Services (“ISS”), that Inter Pipeline Ltd. (“IPL”) Shareholders vote AGAINST IPL’s proposed transaction (the “Alternative Transaction”) with Pembina Pipeline Corporation (“Pembina”). Recommendation cites execution risk of the Alternative Transaction and a higher bid from Brookfield Infrastructure which offers financing certainty, no regulatory risk, and an all-cash option
Brookfield Infrastructure’s Offer to purchase IPL for $21.23 per IPL common share1, on a prorated basis, represents a premium of C$1.53 or 8%2to the Alternative Transaction
Shareholders may elect up to 100% cash consideration totalling C$20.00 per share of IPL without being subject to proration or 0.250 of a class A exchangeable subordinated voting...
Eve & Co. Announces Medical Cannabis Supply & Purchase Agreement With Cannamedical Pharma GmbH
Written by Customer Service on . Posted in Public Companies.
STRATHROY, Ontario, July 19, 2021 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co”, “we”, “us” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF), is pleased to announce that its wholly-owned subsidiary, Natural MedCo Ltd. (“NMC”) has successfully entered into a Medical Cannabis Supply and Purchase Agreement (the “Agreement”) with Cannamedical Pharma® GmbH (“CM”), an import / export and distribution company of para-pharmaceutical, medicinal and narcotic products headquartered in Cologne, Germany.
Pursuant to the Agreement, NMC will export medical graded dried cannabis flower to CM and CM will distribute medical graded cannabis products in Germany. CM specializes in the import and distribution of medicinal cannabis to pharmacies and clinical facilities in the European Union (the “EU”).
“We are very pleased to be able to...
Grom Social Enterprises to Present at the Emerging Growth Conference on Wednesday, July 21, 2021
Written by Customer Service on . Posted in Public Companies.
BOCA RATON, FL, July 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Grom Social Enterprises, Inc. (NASDAQ: GROM) (“Grom”, the “Company”), a social media platform and original content provider for children under the age of 13, is pleased to announce that it has been invited to present at the Emerging Growth Conference on Wednesday, July 21, 2021
The next Emerging Growth Conference is presenting on Wednesday, July 21, 2021. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s CEO Darren Marks and Grom Social’s President, Paul Ward in real time.
Mr. Marks and Mr. Ward will perform a presentation and may subsequently open the floor for questions. Please ask your questions during the event and Mr. Marks and Mr. Ward will do their best to get...
Pluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Directors
Written by Customer Service on . Posted in Public Companies.
Pluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of DirectorsPluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of DirectorsHAIFA, Israel, July 19, 2021 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading biotechnology company, today announced the Board of Director appointments of Prof. Varda Shalev, a physician, medical researcher, and Professor of Medicine at the Tel Aviv University’s School of Public Health, and Mr. Doron Birger, a high-tech industry executive with a background in bringing groundbreaking products to market.
Prof. Shalev has more than 30 years of experience working in clinical environments and research settings at the intersection of health and technology. She was the founder and Chief Executive Officer...
Eluminex Biosciences Exclusively Licenses FibroGen’s Biosynthetic Cornea Technology and Recombinant Collagen III Platform
Written by Customer Service on . Posted in Public Companies.
Exclusive Global Development and Commercialization Rights for Recombinant Human Collagen-Based Biosynthetic CorneaClinical Stage Asset Has Potential for First Approved Biosynthetic Human CorneaBiosynthetic Cornea Designed to Address Significant Unmet Need in Global Demand for Corneal Grafts for the Treatment of Corneal BlindnessEdward Holland, MD, Joins Eluminex’s Scientific Advisory BoardSUZHOU, China and SAN FRANCISCO, July 19, 2021 (GLOBE NEWSWIRE) — Eluminex Biosciences (Suzhou) Limited (Eluminex), an ophthalmology-focused biotechnology company headquartered in Suzhou, China with a US-subsidiary office in San Francisco Bay Area, California, announced today that it has exclusively licensed global rights for the development and commercialization of an investigational biosynthetic cornea derived from recombinant human...
REGO Payment Architectures, Inc. Announces Upcoming Release of Mazoola(SM) version 3.0 and its unique “Super App” Capabilities
Written by Customer Service on . Posted in Public Companies.
Because your child’s privacy matters
The Children’s Online Privacy Protection Act (“COPPA”) and the General Data Protection Regulation (“GDPR”) compliance drive world-class privacy and consent policy features
BLUE BELL, Pa., July 19, 2021 (GLOBE NEWSWIRE) — REGO Payment Architectures, Inc. (“REGO”) (OTCQB:RPMT) today announced the upcoming launch of its MazoolaSM version 3.0, a digital-wallet platform that allows children to fully participate in the digital economy in a secure and protected manner. The super app is scheduled to be released August 9th and expected to quickly become a perennial leader in the family neobanking, digital wallet space. As the only certified COPPA and GDPR compliant super app and with mounting pressure to protect children’s identity, MazoolaSM is uniquely positioned to address the 70M+ Gen Z Kids and...
Sigilon Therapeutics Appoints Ajay Rai, M.B.A., as Senior Vice President, Head of Business Development
Written by Customer Service on . Posted in Public Companies.
CAMBRIDGE, Mass., July 19, 2021 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today announced the appointment of Ajay Rai, M.B.A., as Senior Vice President, Head of Business Development. Most recently, Mr. Rai served as Vice President, Corporate Development, Strategy & Alliance Management at Frequency Therapeutics where he was responsible for evolving the company’s overall business and corporate strategy and played an integral role in executing several financing rounds, including an Initial Public Offering.
“We are pleased to welcome Ajay to our team, as he brings over two decades of business development, finance and partnering experience in the life sciences,” said Rogerio...
Intercept to Announce Second Quarter 2021 Financial Results on July 29, 2021
Written by Customer Service on . Posted in Public Companies.
NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its second quarter 2021 financial results prior to market open on Thursday, July 29, 2021. The announcement will be followed by a conference call and audio webcast hosted by Intercept management at 8:30 a.m. ET to discuss the results.
The conference call will be available on the investor page of our website at http://ir.interceptpharma.com or by calling (855) 232-3919 (toll-free domestic) or (315) 625-6894 (international) passcode 2919379. Archived webcasts will be available on Intercept’s website for approximately two weeks.
About Intercept
Intercept is a biopharmaceutical company...